Open-label study of long-term administration of dotinurad in Japanese hyperuricemic patients with or without gout

ConclusionDotinurad at doses of 2 –4-mg sufficiently reduced serum uric acid levels in hyperuricemic patients with or without gout, and its efficacy and safety were verified for long-term administration.ClinicalTrials.gov Identifier: NCT03006445
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research